Experts discuss benefits and risks of different guideline-approved treatment approaches for C. difficile infection

In a new Annals “Beyond the Guidelines” feature, an infectious diseases specialist and a gastroenterologist discuss the benefits and risks of different treatment approaches for Clostridioides difficile infection (CDI). The experts consider clinical practice guidelines and provide rationale for how their recommendations may or may not fall within those guidelines.